Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. Thalidomide may stop the growth of cancer by stopping blood flow
to the tumor. Combining dexamethasone and thalidomide may kill more cancer cells. It is not
yet known whether dexamethasone is more effective with or without thalidomide in treating
multiple myeloma.
PURPOSE: Randomized phase III trial to determine the effectiveness of dexamethasone with or
without thalidomide in treating patients who have multiple myeloma.